# rs11629191 and Breast cancer

Configuration `single`, named mode, seed 0. Models: generator openai/gpt-6-luna, critic openai/gpt-6-luna, summariser openai/gpt-6-luna. Cost $0.00 over 1 model calls; 48 s.

Variant `chr14:55887040:C>T` (germline); expression context: DepMap:ACH-000019 (MCF7).

## Ranked chains

### 1. H0: Null: no TF-mediated effect of rs11629191 (p = 0.55)

Null chain: no TF-mediated effect of this variant.

Predictions: The C and T alleles will not show a reproducible TF-dependent difference in regulatory activity at this site; any disease association could reflect linkage or chance.

Falsified if: A reproducible allele-dependent regulatory effect at this site is demonstrated and depends on a TF binding the variant.

### 2. H1: Speculative ESR1-dependent regulatory effect (p = 0.20)

TF ESR1 (QBiC-SELEX coverage own_model), alt allele binds more; element Putative cis-regulatory element containing rs11629191; gene None; cell type MCF7.

| Step | Claim | Status | Evidence |
| --- | --- | --- | --- |
| binding | As a provisional candidate, ESR1 is hypothesized to bind the T allele more strongly; no occupancy or QBiC-SELEX result is supplied here, so this direction is an untested guess rather than an evidence-based assignment. | missing | none |
| element | The variant is hypothesized to lie in a regulatory element whose activity is altered by ESR1 binding, but element activity is unverified. | missing | none |
| gene | The affected target gene is unknown; this hypothesis predicts that the element regulates a gene relevant to breast cancer. | missing | none |
| cell_type | The proposed effect is hypothesized to occur in MCF7 cells, without evidence that ESR1 occupies this site there. | missing | none |
| phenotype | If the regulatory change alters the relevant target gene, it could influence breast cancer risk; the direction of that disease effect is unknown. | missing | none |

Predictions: An allele-specific reporter effect should be reduced by ESR1 depletion; the predicted binding direction is greater for T than C.; The target gene and whether increased ESR1 binding activates or represses it cannot be predicted from the information provided.

Falsified if: ESR1 shows no allele-dependent binding or regulatory effect in an informative assay, or ESR1 depletion leaves the allele-specific effect unchanged.

### 3. H2: Speculative FOXA1-dependent regulatory effect (p = 0.15)

TF FOXA1 (QBiC-SELEX coverage own_model), ref allele binds more; element Putative cis-regulatory element containing rs11629191; gene None; cell type MCF7.

| Step | Claim | Status | Evidence |
| --- | --- | --- | --- |
| binding | As a provisional alternative, FOXA1 is hypothesized to bind the C allele more strongly; no site occupancy or QBiC-SELEX result is supplied here, so the direction is untested. | missing | none |
| element | The variant is hypothesized to alter FOXA1-dependent activity of a cis-regulatory element, which has not been established. | missing | none |
| gene | The target gene is unknown; this hypothesis predicts regulation of a breast-cancer-relevant gene. | missing | none |
| cell_type | The proposed effect is hypothesized to occur in MCF7 cells, but FOXA1 occupancy at the variant is not established. | missing | none |
| phenotype | A FOXA1-dependent change in the unknown target gene could affect breast cancer risk, with no supported prediction for the direction. | missing | none |

Predictions: An allele-specific regulatory effect should track FOXA1 binding and be reduced by FOXA1 depletion; the predicted binding direction is greater for C than T.; The predicted FOXA1 dependence distinguishes this candidate from the ESR1 and CTCF candidates.

Falsified if: FOXA1 depletion does not affect an allele-specific regulatory signal, or informative assays show no greater FOXA1 binding to C.

### 4. H3: Speculative CTCF-dependent regulatory effect (p = 0.10)

TF CTCF (QBiC-SELEX coverage own_model), alt allele binds more; element Putative cis-regulatory element containing rs11629191; gene None; cell type MCF7.

| Step | Claim | Status | Evidence |
| --- | --- | --- | --- |
| binding | As a provisional alternative, CTCF is hypothesized to bind the T allele more strongly; no occupancy or QBiC-SELEX result is supplied here, so this direction is untested. | missing | none |
| element | The variant is hypothesized to alter a CTCF-associated regulatory or chromatin-contact element, but neither such an element nor a contact is established. | missing | none |
| gene | The target gene is unknown; this hypothesis predicts that altered CTCF binding changes regulation of a breast-cancer-relevant gene. | missing | none |
| cell_type | The proposed effect is hypothesized to occur in MCF7 cells, without evidence of CTCF occupancy at this site in those cells. | missing | none |
| phenotype | If altered CTCF binding changes target-gene regulation, it could influence breast cancer risk; the direction is unknown. | missing | none |

Predictions: An allele-specific regulatory effect should track CTCF binding and be reduced by CTCF depletion; the predicted binding direction is greater for T than C.; A CTCF-dependent effect could involve altered chromatin contacts rather than a simple enhancer-output change.

Falsified if: CTCF depletion does not affect the allele-specific regulatory signal, or informative assays show no greater CTCF binding to T.

## Prediction matrix

| Test | Cost | Separates top two | H0 | H1 | H2 | H3 |
| --- | --- | --- | --- | --- | --- | --- |
| Low-cost allele-specific reporter assay in MCF7 cells, comparing C and T constructs with control versus ESR1 depletion | low | yes | No reproducible C-versus-T reporter difference, or any difference is not ESR1-dependent. | A reproducible C-versus-T reporter difference is reduced by ESR1 depletion; the binding hypothesis predicts stronger ESR1 binding to T. | An allele-specific difference, if present, is not specifically reduced by ESR1 depletion; this test alone does not establish FOXA1 dependence. | An allele-specific difference, if present, is not specifically reduced by ESR1 depletion; this test alone does not establish CTCF dependence. |

## Next experiment

Run the allele-specific reporter assay in MCF7 cells with and without ESR1 depletion. It is the cheapest proposed test that directly distinguishes the leading ESR1-dependent chain from the null, although a positive result would still require confirmation at the endogenous locus.

## Flags

- none

## Evidence
